AU5466690A - Maleinimide-derivatives and their use as pharmaceuticals - Google Patents

Maleinimide-derivatives and their use as pharmaceuticals

Info

Publication number
AU5466690A
AU5466690A AU54666/90A AU5466690A AU5466690A AU 5466690 A AU5466690 A AU 5466690A AU 54666/90 A AU54666/90 A AU 54666/90A AU 5466690 A AU5466690 A AU 5466690A AU 5466690 A AU5466690 A AU 5466690A
Authority
AU
Australia
Prior art keywords
pharmaceuticals
derivatives
maleinimide
thromboses
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU54666/90A
Other versions
AU634541B2 (en
Inventor
Hubert Dr. Barth
Hans-Jurgen Dr. Betche
Johannes Dr. Hartenstein
Hartmut Prof. Dr. Osswald
Reinhard Dr. Reck
Claus Dr. Rudolph
Christoph Dr. Schachtele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3914764A external-priority patent/DE3914764A1/en
Priority claimed from DE19893942991 external-priority patent/DE3942991A1/en
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of AU5466690A publication Critical patent/AU5466690A/en
Application granted granted Critical
Publication of AU634541B2 publication Critical patent/AU634541B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Aerodynamic Tests, Hydrodynamic Tests, Wind Tunnels, And Water Tanks (AREA)
  • Image Processing (AREA)

Abstract

The invention relates to novel bis(1H-indol-3-yl)maleimide derivatives, a process for their preparation, pharmaceuticals containing these compounds and their use for the treatment of cardiac and vascular diseases such as thromboses, arteriosclerosis, hypertension, inflammatory processes, allergies, cancer and certain types of degenerative damage of the central nervous system and also disorders of the immune system and viral diseases.
AU54666/90A 1989-05-05 1990-05-04 Maleinimide-derivatives and their use as pharmaceuticals Ceased AU634541B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3914764A DE3914764A1 (en) 1989-05-05 1989-05-05 New bis(1H-indol-3-yl) maleinimide derivs. - are inhibitors of protein kinase C for treatment of cardiovascular, CNS and immune system disorders
DE3914764 1989-05-05
DE19893942991 DE3942991A1 (en) 1989-12-27 1989-12-27 New 2,3-bis:indolyl-maleimide derivs.
DE3942991 1989-12-27

Publications (2)

Publication Number Publication Date
AU5466690A true AU5466690A (en) 1990-11-08
AU634541B2 AU634541B2 (en) 1993-02-25

Family

ID=25880591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54666/90A Ceased AU634541B2 (en) 1989-05-05 1990-05-04 Maleinimide-derivatives and their use as pharmaceuticals

Country Status (16)

Country Link
EP (1) EP0397060B1 (en)
JP (1) JP2983248B2 (en)
KR (1) KR900018080A (en)
AT (1) ATE209202T1 (en)
AU (1) AU634541B2 (en)
CA (1) CA2015996C (en)
DE (1) DE59010927D1 (en)
DK (1) DK0397060T3 (en)
ES (1) ES2169719T3 (en)
FI (1) FI902251A0 (en)
HU (1) HU207727B (en)
IL (1) IL94274A0 (en)
NO (1) NO179748C (en)
NZ (1) NZ233560A (en)
PT (1) PT93947B (en)
YU (1) YU87990A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623630B2 (en) * 1988-02-10 1992-05-21 F. Hoffmann-La Roche Ag 3 (3-indoyl) pyrrole-2,5-dione derivatives

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005970A1 (en) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh NEW TRISUBSTITUTED MALEINIMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4243321A1 (en) * 1992-12-21 1994-06-23 Goedecke Ag Amino acid derivatives of heterocycles as PKC inhibitors
US5405864A (en) * 1993-10-15 1995-04-11 Syntex (U.S.A.) Inc. Chemotherapeutic maleimides
BR9404831A (en) * 1993-12-07 1995-08-08 Lilly Co Eli Compound, pharmaceutical formulation and process for preparing a compound
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
DK0657411T3 (en) * 1993-12-07 1999-11-15 Lilly Co Eli Improved synthesis of bisindolylmaleimides
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
AU1339895A (en) 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
ATE283863T1 (en) * 1994-05-09 2004-12-15 Banyu Pharma Co Ltd METHOD FOR PRODUCING INDOLOPYRROLOCARBAZOLE DERIVATIVES
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
ES2145978T3 (en) * 1995-11-20 2000-07-16 Lilly Co Eli INTERMEDIATES AND THEIR USE TO PREPARE BISINDOLYL MALEIMIDES WITH A BRIDGE N, N '.
PE91498A1 (en) * 1996-07-29 1998-12-22 Hoffmann La Roche SUBSTITUTED PYRROLES
PE91698A1 (en) * 1996-07-29 1998-12-24 Hoffmann La Roche SUBSTITUTED PYRROLES
PE91598A1 (en) * 1996-07-29 1998-12-24 Hoffmann La Roche SUBSTITUTED PYRROLES
SE9603283D0 (en) * 1996-09-10 1996-09-10 Astra Ab New compounds
WO1998018466A2 (en) * 1996-10-31 1998-05-07 Harbor Branch Oceanographic Institution, Inc. Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
EP1057484A4 (en) * 1998-02-23 2002-11-20 Sagami Chem Res Cell death inhibitors
DE69920455T2 (en) 1998-07-08 2005-01-20 Harbor Branch Oceanographic Institution Inc., Fort Pierce BIS-INDOLEDERIVATE AND ITS USE AS AN INFLAMMATORY AGENT
WO2000047575A1 (en) * 1999-02-09 2000-08-17 Sagami Chemical Research Center Pyrrole derivatives and cell death inhibitors
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
DE10109280A1 (en) * 2001-02-26 2002-09-05 Peter Mayser Indole derivatives with inhibitory effects on protein kinases
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
IL161156A0 (en) 2001-10-30 2004-08-31 Novartis Ag Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
JPWO2004091663A1 (en) * 2003-04-18 2006-07-06 協和醗酵工業株式会社 Nerve regeneration drug
SI1846406T1 (en) 2005-02-09 2011-02-28 Arqule Inc Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
WO2009002806A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
WO2009002807A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Indolyl pyrrolidines for the treatment of cancer
MX2009013815A (en) 2007-06-22 2010-03-01 Arqule Inc Quinazolinone compounds and methods of use thereof.
US8193235B2 (en) * 2009-06-12 2012-06-05 University Of Kansas Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
CZ280738B6 (en) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituted pyrroles, their use for preparing medicaments and medicaments based thereon

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623630B2 (en) * 1988-02-10 1992-05-21 F. Hoffmann-La Roche Ag 3 (3-indoyl) pyrrole-2,5-dione derivatives

Also Published As

Publication number Publication date
HU902681D0 (en) 1990-09-28
CA2015996A1 (en) 1990-11-05
KR900018080A (en) 1990-12-20
NO901989D0 (en) 1990-05-04
NO179748C (en) 1996-12-11
CA2015996C (en) 2001-08-28
FI902251A0 (en) 1990-05-04
EP0397060A3 (en) 1992-01-02
EP0397060A2 (en) 1990-11-14
EP0397060B1 (en) 2001-11-21
PT93947A (en) 1991-01-08
DK0397060T3 (en) 2002-05-21
ES2169719T3 (en) 2002-07-16
YU87990A (en) 1992-07-20
NO179748B (en) 1996-09-02
HU207727B (en) 1993-05-28
ATE209202T1 (en) 2001-12-15
PT93947B (en) 1996-11-29
IL94274A0 (en) 1991-03-10
JPH02306974A (en) 1990-12-20
NZ233560A (en) 1992-01-29
HUT53902A (en) 1990-12-28
DE59010927D1 (en) 2002-01-03
NO901989L (en) 1990-11-06
AU634541B2 (en) 1993-02-25
JP2983248B2 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
AU634541B2 (en) Maleinimide-derivatives and their use as pharmaceuticals
AU4319493A (en) Indolocarbazole imides and their use
ZA895969B (en) Alkoxy-4(1h)-pyridone derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PL298988A1 (en) Novel derivatives of acetic acod, pharmaceutical preparation, method of obtaining such derivatives and method of obtaining initial compounds
EP0434057A3 (en) Indolocarbazole derivatives, processes for their preparation and their use
GR3003452T3 (en) Indolocarbazole derivatives, processes for their preparation and their use as medicaments
FI884553A0 (en) Analogous Process for the Preparation of Therapeutically Useful 9-Aminotetrahydroacridine Derivatives
WO1989000571A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ZA898274B (en) 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments
AU563990B2 (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives